Women’s Preventive Laboratory Panel

The Women’s Preventive Laboratory Panel is a broad laboratory assessment designed to provide an overview of several important areas of adult women’s health. It combines blood testing with urine analysis and a fecal occult blood test, allowing multiple health indicators to be reviewed as part of one preventive laboratory pathway.

The panel can help identify laboratory findings that may require lifestyle changes, repeat testing, a medical consultation, or more targeted diagnostic evaluation. It does not provide a complete health assessment on its own and cannot confirm or exclude a disease without considering medical history, symptoms, medications, age, and individual risk factors.

What the panel includes

The confirmed panel combines the following tests:

• Blood count and iron status: complete blood count, serum iron, and ferritin.
• Blood sugar and metabolism: glucose, HbA1c, and uric acid.
• Blood lipids: total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides.
• Thyroid function: TSH, free T3, and free T4.
• Kidney-related indicators: urea and creatinine.
• Liver and protein-related indicators: total bilirubin, total serum protein, AST, ALT, GGT, alkaline phosphatase, and LDH.
• Pancreatic and muscle enzymes: amylase, lipase, and creatine kinase.
• Minerals and electrolytes: phosphorus, calcium, potassium, magnesium, and sodium.
• Inflammation: C-reactive protein.
• Women’s health marker: CA125.
• Additional samples: urine dipstick with sediment examination and fecal occult blood testing.

Together, these tests can provide information about anemia and iron stores, glucose regulation, lipid levels, thyroid function, kidney and liver indicators, inflammatory activity, mineral balance, and selected digestive or urinary findings.

Who may consider the panel

The panel may be considered by adult women who want a broad preventive laboratory baseline, have not completed routine laboratory testing recently, or want to review several health indicators in one testing pathway. It may also be useful when previous results showed borderline changes that require periodic monitoring.

Preventive testing should be adapted to age, personal and family history, current symptoms, pregnancy status, medications, and known medical conditions. Women with a specific concern may require a focused test, imaging examination, gynecologic evaluation, or specialist consultation in addition to, or instead of, a broad laboratory panel.

How the testing process works

Step 1: Preparation and sample instructions

Because the panel includes glucose and lipid measurements, testing is generally performed after fasting for 8 to 10 hours. Plain water is permitted. Medications should not be stopped or changed unless this has been agreed with a physician.

The panel also requires urine and stool samples. Collection containers and instructions should be obtained before testing when needed. The immunochemical fecal occult blood test does not require a special diet. Stool sampling should be postponed during menstruation, diarrhea, active hemorrhoidal bleeding, or visible blood in the urine because these situations may affect interpretation.

Step 2: Blood collection

A venous blood sample is collected during a routine blood draw. The collection itself usually takes only a few minutes. Temporary discomfort, mild bruising, or lightheadedness may occur.

Step 3: Urine and stool submission

The urine and stool samples are submitted in the appropriate containers according to the collection instructions. The complete panel can be finalized only after all required samples have been received.

Step 4: Laboratory analysis

The samples are analyzed for the confirmed blood, urine, and stool parameters. Results are generally expected within approximately three hours after all required samples have been received, although verification, repeat analysis, or delayed sample submission may extend the final reporting time.

Step 5: Interpretation and next steps

Results should be reviewed as a complete pattern rather than as isolated numbers. A value outside the reference range does not automatically mean that a disease is present. Temporary illness, hydration, medications, recent physical activity, menstrual status, and other factors may influence individual measurements.

Understanding CA125

CA125 is included in the panel, but it is not a stand-alone ovarian cancer screening test. An elevated result does not diagnose cancer and may occur with noncancerous gynecologic or other medical conditions. A result within the reference range also cannot independently exclude ovarian cancer.

CA125 should therefore be interpreted together with symptoms, personal and family history, previous findings, and, when medically indicated, gynecologic examination or imaging. It does not replace recommended cervical, breast, or other age- and risk-appropriate cancer screening.

What the results may help clarify

The report may identify findings such as anemia, reduced iron stores, abnormal glucose regulation, altered cholesterol levels, thyroid hormone changes, inflammation, or changes in liver, kidney, pancreatic, urinary, or digestive indicators. These findings may help guide a discussion about nutrition, medication, repeat testing, preventive care, or further diagnostic assessment.

A positive fecal occult blood result is not a diagnosis of colorectal cancer. It indicates that blood was detected in the sample and usually requires medical evaluation to determine the source and whether further testing is appropriate.

Role within preventive care

This panel is a laboratory component of preventive care, not a complete systematic examination. It does not replace a medical history, physical examination, blood pressure measurement, gynecologic care, cervical screening, breast screening, or other evaluations recommended according to age and individual risk.

For a ZagrebMed inquiry, it is useful to provide your age, reason for testing, current medications, relevant diagnoses, pregnancy status, and previous laboratory reports. ZagrebMed can help clarify whether this broad panel or a more focused laboratory or specialist pathway better matches the purpose of your assessment.